<DOC>
	<DOCNO>NCT01717027</DOCNO>
	<brief_summary>To estimate pharmacokinetics relative bioavailability oxycodone administration 40 mg dos PF-00345439 formulation take whole fed condition chew fasted condition healthy volunteer</brief_summary>
	<brief_title>Pharmacokinetics And Relative Bioavailability Study Of Oxycodone Healthy Volunteers</brief_title>
	<detailed_description>This study estimate pharmacokinetics relative bioavailability oxycodone follow oral administration single 40 mg dos PF-00345439 Formulations J K compare reference PF-00345439 Formulation A , take whole fed condition healthy volunteer . In addition , study estimate pharmacokinetics relative bioavailability oxycodone followingoral administration single 40 mg dos PF-00345439 Formulation J K ( beselected base Periods 1-3 ) chew fast condition compare take whole fed state healthy volunteer , assess single-dose safety tolerability oxycodone inPF-00345439 formulation healthy volunteer administer naltrexone block .</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Healthy male and/or female subject 18 55 year age ( inclusive ) . Evidence history clinically significant disease . Positive urine drug test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioavailability</keyword>
	<keyword>oxycodone</keyword>
	<keyword>management moderate severe pain</keyword>
</DOC>